Skip to content
Open access

Phytochemical Network Pharmacology in Alzheimer's disease: Multi-Target Neuroprotective Strategies and Emerging Drug Delivery Approaches

Oct 2026 · Journal of Innovations in Applied Pharmaceutical Science (JIAPS) · pp. 74-79 · 0 citations

TL;DR

This integrated approach constructs compound target-disease-pathway interactomes, showing polypharmacological synergy in modulating key hubs involved in APP, GSK-3β, NF-κB, PI3K/Akt, and MAPK cascades, thus inhibiting Aβ plaque deposition, tau pathology, microglial activation, apoptosis, and improving neurotrophic support.

Abstract

Alzheimer's disease (AD) is a fatal neurodegenerative disorder, which features a host of characteristics: Aβ aggregation, tau hyperphosphorylation, neuroinflammation, oxidative stress, and synaptic loss. Most single-target drugs have proven to be inefficient in combating the disease. Phytochemical network pharmacology is a revolutionary approach in which a library of natural products from plants is systematically connected with multifaceted pathological networks in AD by use of bioinformatics tools such as Cytoscape, SwissTargetPrediction, and molecular docking. This integrated approach constructs compound target-disease-pathway interactomes, showing polypharmacological synergy in modulating key hubs involved in APP, GSK-3β, NF-κB, PI3K/Akt, and MAPK cascades, thus inhibiting Aβ plaque deposition, tau pathology, microglial activation, apoptosis, and improving neurotrophic support. Despite their encouraging neuroprotective profiles, the limiting factors associated with phytochemicals concern poor bioavailability and impermeability through the blood-brain barrier. Integration into advanced drug delivery systems such as nanoparticles, liposomes, and ligand modification of nanocarriers enables receptor-mediated transcytosis, sustained release, and targeted brain accumulation, hence surpassing such drawbacks. Such is illustrated by curcumin-loaded formulations inducing the Nrf2/HO-1 antioxidant pathways. This may support the rational design of multi-component herbal therapies through in silico simulation, preclinical models of cognitive restoration, and pathway enrichment analyses. The major challenges remain standardization and clinical translation; however, future potential in precision AD interventions could arise from AI-driven predictions and pharmacogenomics, shifting the current symptomatic palliation to disease-modifying polypharmacology.

Read PDF

Similar papers

Review Open access Oct 2026

Therapeutic Potential of Marine Natural Products Against Alzheimer’s Disease: Molecular Mechanisms, Druggability Evaluation and Clinical Translation Barriers

Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder with complex multifactorial pathological cascades, including amyloid-β (Aβ) aggregation, tau hyperphosphorylation, sustained neuroinflammation, oxidative stress, cholinergic dysfunction and gut–brain axis imbalance. Current marketed anti-AD drugs me...

Dao-Wei Huang, Rou-Jun Lu, Chen-Chen Sheng et al. · 0 citations
Open access Oct 2026

MULTI-TARGET MECHANISTIC INSIGHTS INTO GARLICMEDIATED NEUROPROTECTION IN ALZHEIMER’S DISEASE USING NETWORK PHARMACOLOGY, MOLECULAR DOCKING, AND IN VITRO VALIDATION

This study shows that Allium sativum has the ability to modulate important proteins and signaling pathways linked to cognitive impairment, neurodegeneration, inflammation, and oxidative stress, suggesting that it could be a natural treatment option for Alzheimer's disease.

Bhumika Gurve, Tabbasum Tamboli, Shubham.U. Nalawade et al. · 0 citations
Review Oct 2026

Phytochemicals in Alzheimer's disease: Mechanistic Insights, Targets, and Future Directions.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory impairment, cognitive decline, and behavioral alterations. It is the most common form of dementia among older adults and represents a major global health, social, and economic burden. Current pharmacological interventions prima...

Anuradha Mehra, Amit Mittal · 0 citations
Open access Oct 2026

Synthesis and Biological Evaluation of Benzimidazole Derivatives Targeting Neurodegeneration in Alzheimer’s Disease

Alzheimer's disease (AD) is the most prevalent dementia and continues to be a significant public health problem due to its irreversible, progressive and multifactorial pathogenesis. Existing treatment options, such as acetylcholinesterase inhibitors and memantine, are only partially effective in preventing the death of...

A. Mazumdar, Rashmi Mishra, Himank Varshney et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.